Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
Clinical trial NCT00050986 · COMPLETED
Trial details
- NCT number
- NCT00050986
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2008-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.